explore -WSS

explore

author：hotspot 2025-08-11 11:40:56 - browse：733

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine.

The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise. Clinical trials have shown the one-time treatment enabled many sickle cell patients to live free of debilitating pain crises and relieved thalassemia patients of needing regular blood transfusions, raising hopes that they have been effectively cured. But it also stands as a major achievement, coming just over a decade after the first and seminal lab experiments that showed CRISPR’s potential as a gene-editing tool were published.

In granting conditional approval to the therapy, which will have the brand name Casgevy and is also known as exa-cel, the U.K.’s Medicines and Healthcare products Regulatory Agency jumped ahead of its counterparts in the U.S. and Europe, which are also reviewing the medicine, in greenlighting the globe’s first CRISPR treatment. The MHRA’s authorization is for patients who are at least 12 years old.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Pediatric cancer treatments threatened by a new FDA policy

focus

WSS

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

When prostate cancer spreads, where it goes matters

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Military medical care influenced by rank and race, new study finds

UnitedHealth’s Optum accused of antitrust violations in California

With clinical trial data readouts, here's how to spot spin

knowledge

explore

leisure time

United colonoscopy coverage change 'may cost lives,' doctors say

How to pay for weight loss drugs and save Medicare

Affirmative action in medical school literally saved lives

Diagnostic tests are hitting their mathematical limits

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

What does generative AI mean for health care? We asked experts

Second House panel advances two

Hepatitis C has a cure — but many Americans still lack access to it

U.K. Biobank has 500,000 peoples' genome sequences available

entertainment

Fetal surgery at risk from Dobbs and new abortion restrictions

Will the market for weight loss drugs really reach $100 billion?

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Criminal prosecution for violating HIPAA: an emerging threat

Helping hospitals and community health centers plan for resilience

30 years of 'Listening to Prozac'

entertainment

focus

focus

explore